Johan Heylen

Biography

 Johan assumes responsibility for all Ablynx’s commercial activities and late stage project management. He has more than 20 years of experience in global biopharmaceutical sales, marketing and business development at GlaxoSmithKline (GSK), Servier and Wyeth. Prior to joining Ablynx, Johan was Executive Director, Global Commercial Lead, Cancer Immunotherapeutics, at GSK, where he headed the global commercial teams and was responsible for the development and implementation of the launch strategy for GSK’s cancer immunotherapeutics portfolio. Prior to that, Johan led and launched the successful global commercial and marketing efforts for three of GSK’s paediatric vaccines, Rotarix®, Priorix® and Varilrix®, which together achieved sales of more than €1.5 billion. He has experience in a wide range of therapeutic fields and regions, having worked and lived in Europe, Latin-America, Asia and in the USA.

Research Interest

 pharmacy, economics, management